Models of blood coagulation

被引:94
作者
Mann, KG [1 ]
Brummel-Ziedins, K [1 ]
Orfeo, T [1 ]
Butenas, S [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Colchester, VT 05446 USA
关键词
thrombosis; hemostasis; biochemistry; physiology;
D O I
10.1016/j.bcmd.2005.12.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our research aims to provide quantitatively transparent, biologically realistic descriptions of the processes involved in hemostasis which will pen-nit predictions of the behavior of the coagulation system in normal and pathologic states. We use four models of coagulation: (1) numerical approximations of the tissue factor (Tf) pathway of thrombin generation based upon mechanism and dynamics; (2) Tf activation of the "blood coagulation proteome" from isolated cells and proteins; (3) Tf activated contact pathway inhibited whole blood in vitro; and (4) blood shed from standardized microvascular wounds in vivo. The results from these models are integrated in interactive assessments aimed at achieving convergence of biochemical rigor and biological authenticity. Microvascular injury is the most biologically secure but least accessible to mechanistic study. Numerical models while quantitatively transparent are biologically limited. By the integrated analyses of all four models, we establish observations which require inclusion or discovery of new parameters to achieve mechanistically interpretable biological reality. Discoveries made in this fashion have included thrombin's role in the initiation phase, TFPI/ATIII/APC synergy interactions, rfVIIa in fVII deficiency, the roles of fVIII and fIX in the Tf reaction, and the cleavage of fIX by fXa membrane. Ideally, our results will provide descriptions which predict the behavior of the biological blood coagulation system under normal and pathologic conditions. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:108 / 117
页数:10
相关论文
共 127 条
[1]   COMPONENTS AND ASSEMBLY OF THE FACTOR-X ACTIVATING COMPLEX [J].
AHMAD, SS ;
RAWALASHEIKH, R ;
WALSH, PN .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1992, 18 (03) :311-323
[2]   Advances in anticoagulation therapy: The role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery [J].
Andersen, JC .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06) :609-618
[3]   Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor [J].
Baugh, RJ ;
Broze, GJ ;
Krishnaswamy, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4378-4386
[4]   Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease [J].
Becker, RC ;
Alexander, J ;
Dyke, CK ;
Harrington, RA .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) :1182-1193
[5]   Elevated clotting factor levels and venous thrombosis [J].
Bertina, RM .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) :395-400
[6]   Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes [J].
Bhatt, DL ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12) :1549-1558
[7]  
Bhattacharyya Maitreyee, 2003, Indian J Pathol Microbiol, V46, P621
[8]   INHERITANCE AND BLEEDING IN FACTOR-XI DEFICIENCY [J].
BOLTONMAGGS, PHB ;
WANYIN, BY ;
MCCRAW, AH ;
SLACK, J ;
KERNOFF, PBA .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) :521-528
[9]   THE CONTRIBUTIONS OF CA-2+, PHOSPHOLIPIDS AND TISSUE-FACTOR APOPROTEIN TO THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X BY ACTIVATED FACTOR-VII [J].
BOM, VJJ ;
BERTINA, RM .
BIOCHEMICAL JOURNAL, 1990, 265 (02) :327-336
[10]  
Boos C J, 2005, Eur J Intern Med, V16, P267, DOI 10.1016/j.ejim.2005.02.005